Scarica l'app Stockscreener
1.86
14.11%
0.23
Pre-mercato:
1.93
0.07
+3.76%
Curis Inc Borsa (CRIS) Ultime notizie
Press Release Distribution & PR Platform - ACCESS Newswire
Curis (NASDAQ:CRIS) Coverage Initiated by Analysts at StockNews.com - Defense World
Curis (NASDAQ:CRIS) Now Covered by StockNews.com - Defense World
Curis, Inc. and Aurigene Extend Exclusivity Period of Immuno-Oncology and Precision Oncology Collaboration - marketscreener.com
Form DEFA14A CURIS INC - StreetInsider
Curis, Inc. (NASDAQ:CRIS) Q4 2024 Earnings Call Transcript - MSN
Curis stock plunges to 52-week low at $1.1 amid sharp decline - Investing.com Canada
Curis stock plunges to 52-week low at $1.1 amid sharp decline By Investing.com - Investing.com South Africa
Truist Removes Price Target on Curis Due to Volatility, Low Share Price; Price Target Was $26, Buy Rating Kept - marketscreener.com
Curis targets accelerated approval for emavusertib in PCNSL with 12-18 month enrollment timeline - MSN
HC Wainwright Forecasts Curis’ Q1 Earnings (NASDAQ:CRIS) - Defense World
Analyst Forecasts For Curis, Inc. (NASDAQ:CRIS) Are Surging Higher - Yahoo
Curis to Present at Upcoming Healthcare Conference in April - The Malaysian Reserve
Curis to Present at Upcoming Healthcare Conference in April 2025 - BioSpace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Analysts Just Published A Bright New Outlook For Curis, Inc.'s (NASDAQ:CRIS) - simplywall.st
HC Wainwright Lowers Curis (NASDAQ:CRIS) Price Target to $16.00 - The AM Reporter
Curis stock price target cut to $16 by H.C. Wainwright - Investing.com Australia
Curis stock plunges to 52-week low at $1.97 amid market challenges - Investing.com
Curis, Inc. (NASDAQ:CRIS) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates - Yahoo
Investors Don't See Light At End Of Curis, Inc.'s (NASDAQ:CRIS) Tunnel And Push Stock Down 30% - simplywall.st
Curis: Q4 Earnings Snapshot - CT Insider
Curis Inc (CRIS) Q4 2024 Earnings Call Highlights: Financial Improvements and Promising ... - Yahoo Finance
Curis (NASDAQ:CRIS) Price Target Lowered to $16.00 at HC Wainwright - Defense World
Curis Inc. Reports Q4 2024 Progress and Financials - TipRanks
Curis Inc. Earnings Call: Progress Amidst Challenges - TipRanks
Curis eyes accelerated approval for cancer drug emavusertib By Investing.com - Investing.com South Africa
Earnings call transcript: Curis Q4 2024 reveals reduced losses By Investing.com - Investing.com India
Curis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Curis eyes accelerated approval for cancer drug emavusertib - Investing.com India
Curis Provides Fourth Quarter 2024 Business Update - PR Newswire
Curis Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Curis (NASDAQ:CRIS) Coverage Initiated at StockNews.com - Defense World
Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 - Quantisnow
Curis Inc Entered A Purchase Agreement To Sell 2 Million Shares Of Common Stock - MarketScreener
Indo-Asian News Service - Indo-Asian News Service (IANS)
Biotech Alert: Curis Sets Date for Q4 EarningsKey Updates on IRAK4 Inhibitor Program Expected - Stock Titan
Curis stock hits 52-week low at $2.54 amid sharp annual decline - Investing.com Australia
Curis stock hits 52-week low at $2.54 amid sharp annual decline By Investing.com - Investing.com South Africa
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):